Back to Search Start Over

Embryonic cardioprotection by hydrogen sulphide: studies of isolated cardiac function and ischaemia-reperfusion injury in the chicken embryo.

Authors :
Hess RM
Niu Y
Garrud TAC
Botting KJ
Ford SG
Giussani DA
Source :
The Journal of physiology [J Physiol] 2020 Oct; Vol. 598 (19), pp. 4197-4208. Date of Electronic Publication: 2020 Aug 11.
Publication Year :
2020

Abstract

Key Points: In mammals, pregnancy complications can trigger an embryonic or fetal origin of cardiac dysfunction. However, underlying mechanisms remain uncertain because the partial contributions of the challenge on the mother, placenta or offspring are difficult to disentangle. The avian embryo permits isolation of the direct effects of suboptimal conditions during development on the cardiac function of the offspring, independent of additional effects on the mother and/or the placenta. Therefore, the objectives of this work were to adapt the isolated Langendorff technique using the chicken embryo to study the physiology of the developing heart. Here, we introduce a novel technique and show the utility of the technique for exploring cardioprotective roles of H <subscript>2</subscript> S in the chicken embryo heart. This work lays the foundation for studying the direct effects of H <subscript>2</subscript> S therapy on the embryonic heart independent of effects on the mother and the placenta in adverse development.<br />Abstract: This study adapted the isolated Langendorff preparation to study the chicken embryo heart in response to ischaemia-reperfusion (IR) injury. The utility of the technique was tested by investigating cardioprotective effects of hydrogen sulphide (H <subscript>2</subscript> S) and underlying mechanisms. Embryonic hearts (19 out of 21 days of incubation) mounted on a Langendorff preparation were exposed to IR (30 min ischaemia) after 4 treatments administered randomly, all as a 1 mm bolus, into the perfusate: saline vehicle (control); sodium hydrogen sulphide (NaHS); NaHS plus glibenclamide, an antagonist of K <subscript>ATP</subscript> opening (NaHS Glib), and Glib alone (Glib). Relative to controls, NaHS treatment improved cardiac function after ischaemia (mean ± SD for area under the curve, AUC, for left ventricular developed pressure, LVDP: 1767.3 ± 929.5 vs. 492.7 ± 308.1; myocardial contractility, dP/dt <subscript>max</subscript> : 2748.9 ± 1514.9 vs. 763.7 ± 433.1) and decreased infarct size (22.7 ± 8.0 vs. 43.9 ± 4.2%) and cardiac damage (% change in creatinine kinase, 49.3 ± 41.3 vs. 214.6 ± 155.1; all P < 0.05). Beneficial effects of NaHS were blocked by Glib. Glib alone had no effects. NaHS increased coronary flow rate (CFR) during baseline (mean ± SD for AUC: 134.3 ± 91.6 vs. 92.2 ± 35.8) and post IR (1467 ± 529.5 vs. 748.0 ± 222.1; both P < 0.05). However, this effect was not prevented by Glib. Therefore, the chicken embryo heart is amenable for study via the Langendorff preparation under basal conditions and during IR. The data show that H <subscript>2</subscript> S confers embryonic cardiac protection via opening of myocardial K <subscript>ATP</subscript> channels and not via increasing CFR. H <subscript>2</subscript> S may prove a useful therapeutic agent to protect the human fetal heart against IR injury, as may occur in complicated labour.<br /> (© 2020 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society.)

Details

Language :
English
ISSN :
1469-7793
Volume :
598
Issue :
19
Database :
MEDLINE
Journal :
The Journal of physiology
Publication Type :
Academic Journal
Accession number :
32705691
Full Text :
https://doi.org/10.1113/JP279978